Deltaretrovirus Infections: Clinical Trials

6 trials for Deltaretrovirus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 6 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Terminated 2
Phase 23Completed 2, Terminated 1

Follow Deltaretrovirus Infections: new trials by email Literature Review of Deltaretrovirus Infections trials Research Report on Deltaretrovirus Infections

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)
KW-0761 0.3 mg/kg IV, Placebo (saline) - HTLV-1 Associated Myelopathy
Phase 3TerminatedKyowa Kirin Co., Ltd.662017-05-222022-04-14
Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Tamibarotene - HTLV-I-Associated Myelopathy
Phase 2 / Phase 3TerminatedSt. Marianna University School of Medicine152011-01-012026-10-08
Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
Pentoxifylline, Placebo - HTLV-1, Tropical Spastic Paraparesis
Phase 3CompletedHospital Universitário Professor Edgard Santos482009-09-012015-03-18
Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)
Valproic acid, costicosteroids, valproid acid plus corticosteroids - Paraparesis Spastic Tropical
Phase 3CompletedUniversity of Sao Paulo602008-02-012015-12-03
Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
ciclosporin - HTLV I Associated Myelopathy
Phase 2 / Phase 3CompletedImperial College London72006-08-012021-09-09
Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial
Zidovudine/lamivudine, Placebos - HTLV-I-associated Myelopathy
Phase 2 / Phase 3CompletedImperial College London161999-11-082021-08-25

Narrower conditions

Paraparesis, Tropical Spastic (6)  ·  Immune System Diseases (1)

Broader conditions

Central Nervous System Diseases (6)  ·  Central Nervous System Infections (6)  ·  HTLV-I Infections (6)  ·  Infections (6)  ·  Myelitis (6)  ·  Nervous System Diseases (6)  ·  Neuroinflammatory Diseases (6)  ·  RNA Virus Infections (6)  ·  Retroviridae Infections (6)  ·  Spinal Cord Diseases (6)  ·  Virus Diseases (6)

Interventions

Adrenal Cortex Hormones (1)  ·  Cyclosporine (1)  ·  Pentoxifylline (1)  ·  Sodium Chloride (1)  ·  Valproic Acid (1)  ·  lamivudine, zidovudine drug combination (1)  ·  mogamulizumab (1)  ·  tamibarotene (1)

Sponsors

Imperial College London (2)  ·  Hospital Universitário Professor Edgard Santos (1)  ·  Kyowa Kirin Co., Ltd. (1)  ·  St. Marianna University School of Medicine (1)  ·  University of Sao Paulo (1)

Countries

Brazil (2)  ·  Japan (2)  ·  United Kingdom (2)

Top investigators

Davi Costa, MD (1)  ·  Edgar M Carvalho, MD, PhD (1)  ·  Graham P Taylor (1)  ·  Graham P Taylor, FRCP (1)  ·  Yoshihisa Yamano, MD (1)

Results publications

PMID 16984654, PMID 22720101, PMID 38430272